Navigation Links
Patients who Participated in Pleio GoodStart(TM) Refilled 30% Sooner and 40% More, Averaging 2 Additional Rx Refills per Patient

PHILADELPHIA, Oct. 26 /PRNewswire/ -- Pleio Health Support Systems, Inc. (Pleio) announces updated results of the Pleio GoodStart(TM) medication adherence program. Retrospective analysis of retail pharmacy prescription data from 1,776 patients taking a chronic cardiovascular medication between May 2008 and September 2009, revealed that Pleio GoodStart(TM) had a highly significant impact on medication adherence, resulting in patients refilling an average of two additional 30-day prescriptions during their initial 9-month period on the medication (p<0.001).

Data also showed that patients who participated in the GoodStart(TM) program refilled their prescriptions an average of ten days sooner than control group participants. Collectively, these data demonstrate a significant, sustained improvement in patient medication adherence with the Pleio GoodStart(TM) program.

"Improving people's experience with new prescription medications involves many disciplines. Pleio's technology, pharmacy and manufacturer partners are equally dedicated to improving the patient experience with new prescriptions. These results show that when elderly patients are carefully listened to, stimulated in language they can relate to, and empowered with performance support, adherence challenges are easily overcome."

Pleio GoodStart connects physicians, patients, pharmacies, families and pharmaceutical manufacturers toward their common goal of improved patient adherence. Physicians gain the assurance that their patients will be well-supported and that future patient appointments can be more effective. Pharmacies are provided a new perspective on C&P through training and feedback on patient progress. Patients receive unprecedented interest in their welfare throughout the medication adoption phase, with up to 75 contacts during their first 100 days on therapy. Family and friend support is stimulated through awareness of the issue of adherence and their potential to be an advocate.

About Pleio Health Support Systems, Inc.

Pleio Health Supports Systems, founded in 2006, has offices in Montreal and Boston. Pleio GoodStart(TM) is a sponsored adherence program that helps patients properly adopt new medications and in turn refill more prescriptions over a longer period of time. Pleio GoodStart(TM) is a registered trademark of Pleio Health Support Systems, Inc. For more information, visit or contact Jean Lalonde, at (514) 369-9995 info(at)

SOURCE Pleio Health Support Systems, Inc.

SOURCE Pleio Health Support Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
2. Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
3. Patients Receiving High Radiation at Cedars Sinai File Class Action Lawsuit
4. Novartis drug Tasigna(R) meets primary endpoint in pivotal trial against Gleevec(R) as first-line treatment in chronic myeloid leukemia patients
5. Patients Taking VIMOVO(TM) Showed a Decrease in Incidence of NSAID-Associated Ulcers
6. ULORIC(R) (febuxostat) Demonstrated Efficacy for Management of Hyperuricemia in Patients with Gout
7. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
8. Data from Jazz Pharmaceuticals First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia to be Presented at Upcoming Conferences
9. New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone
10. Breast Cancer Survivors and Patients Encouraged to Have Medical History Readily Available
11. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
Post Your Comments:
(Date:6/24/2016)... FRANCISCO, Calif. , June 24, 2016 /PRNewswire/ ... ), a biopharmaceutical company developing novel therapeutics for ... unmet needs, today announced the closing of its ... of common stock, at the public offering price ... in the offering were offered by GBT. GBT ...
(Date:6/24/2016)... , June 24, 2016 ... Markets has announced the addition of the " ... offering. This ... and provides an updated review, including its applications in ... the total market, which includes three main industries: pharmaceutical ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
Breaking Medicine News(10 mins):